Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.

Cancer research - 15 May 1995

Schultz D C, Vanderveer L, Buetow K H, Boente M P, Ozols R F, Hamilton T C, Godwin A K

Abstract excerpt

We have examined 41 forms of ovarian cancer for genetic alterations on chromosome 9 using a combination of five RFLP DNA probes and 15 simple tandem repeat polymorphisms. Genetic imbalance (i.e., loss of heterozygosity, microsatellite instability, amplification) for 1 or more informative markers on chromosome 9 was observed in 66% (27 of 41) of our tumor panel. Genetic imbalance was observed on 9q in 59% (24 of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carrier Proteins

Share to Chromosome Mapping

Share to Gene Deletion

Share to Molecular Sequence Data

Share to Polymerase Chain Reaction

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 7743516

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.PMID 7743516Read ↗

Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.Semantic proximity Read ↗

Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses.Semantic proximity Read ↗

High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays.Semantic proximity Read ↗

Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer.Semantic proximity Read ↗

Frequent loss of chromosome 9 in human primary non-small cell lung cancer.Semantic proximity Read ↗

Low frequency of CDKN2 mutation in endometrial carcinomas.Semantic proximity Read ↗

FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies.Semantic proximity Read ↗

Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.Semantic proximity Read ↗

Acquired uniparental disomy of chromosome 9p in hematologic malignancies.Semantic proximity Read ↗

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesotheliomaSemantic proximity Read ↗

Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.Semantic proximity Read ↗

Role of chromosome 9 in human bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.